AccuSift provides high-performance metronidazole competitive assay pairings, characterized by exceptional batch-to-batch consistency and optimized for IVD kit development (Lateral Flow, Chemiluminescence, ELISA, POCT). These pairings offer high affinity and specificity, facilitating rapid detection.Metronidazole is primarily used as an antibiotic and antiprotozoal agent for the treatment and prevention of systemic or local infections caused by anaerobic bacteria. It is effective against anaerobic infections in the abdomen, digestive tract, female reproductive system, lower respiratory tract, skin and soft tissues, bones and joints, as well as sepsis, endocarditis, and meningitis. It is also used for antibiotic-associated colitis, and is often combined with tetanus antitoxin (TAT) for tetanus treatment. Additionally, it treats oral anaerobic infections.On October 27, 2017, the World Health Organization's International Agency for Research on Cancer (IARC) classified metronidazole as a Group 2B carcinogen in its preliminary list of carcinogens.Performance Characteristics:
Sensitivity: ELISA IC50: 0.5 ppb; Colloidal Gold: 5 ppb
Source: Mouse Monoclonal Antibody
Recommended Pairing: (Coating) / (Labeling)
Storage: Long-term storage at ≤ –20°C; short-term storage at 2–8°C. Shipped on ice packs.
WeChat
